2m 2m 2m 2m 2m 2m 2m
- $5.2MMarket Cap
- -80.69%1-Year Change
- BiotechnologyIndustry
DERMATA THERAPE (DRMA)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 57
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
U.S. stock futures traded mixed on Tuesday as the Santa Claus rally resumed after Monday's declines. Major indices showed minimal movement with the S&P 500 and Nasdaq 100 slightly lower in premarket trading. Key movers included Fonar Corp surging 24.49% on a take-private deal announcement, TEN Holdings jumping 16.31% on a private placement, Boeing rising 0.58% following an $8.6 billion Pentagon contract, and Freeport-McMoRan gaining 1.36% as copper prices hit record highs. The Fed is expected to hold rates steady in January with 83.9% probability.
12/30/2025, 5:21 AM • Benzinga
Why Is Dermata Therapeutics Stock Surging Wednesday?
Dermata Therapeutics (NASDAQ: DRMA) stock surged 20.10% on Wednesday following the announcement of a $12.4 million private placement offering. The company will issue 2,022,062 common shares and warrants priced at $2.04 per share, with expected gross proceeds of $4.1 million. If warrants are fully exercised, the company could raise an additional $8.3 million. Net proceeds will fund consumer research, OTC acne kit launch activities, and working capital. The stock is trading near its 52-week low of $1.96.
12/24/2025, 11:32 AM • Benzinga
Peers
Statistics
MoreInformation as of 06/02/2026
Company Profile
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Key Executives
- Christopher J. Nardo
- Kyri K. Van Hoose
- Gerald T. Proehl
- David F. Hale
- Maria Bedoya Toro Munera
Current Ownership Distribution
- Insiders3.0M (61.66%)
- Institutions1.3M (26.61%)
- Mutual Funds573,178 (11.73%)
- Other0 (0.00%)